FitLife Brands (FTLF) AI Stock Analysis

• Market Cap: $173.08M
• Dividend Yield: N/A
• Average Volume (3M): 19.92K
• Price to Earnings (P/E): 22.5
• Beta (1Y): 0.68
• Revenue Growth: 3.91%
• EPS Growth: -1.39%
• Country: US
• Employees: 39
• Sector: Consumer Defensive
• Sector Strength: 46
• Industry: Packaged Foods
• EPS (TTM): 0.18
• Shares Outstanding: 9,391,072
• 10 Day Avg. Volume: 15,755
• 30 Day Avg. Volume: 19,916
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: 0.80
• Enterprise Value/Revenue: 2.18
• Enterprise Value/Gross Profit: 5.03
• Enterprise Value/Ebitda: 10.79
• 1Y Price Target: $23.00
• Price Target Upside: 24.80% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2

• Rating: 75 Outperform
• Price Target: $19.00 ▲(3.09% Upside)

FitLife Brands demonstrates strong financial performance and strategic growth through acquisitions, which are key strengths. However, recent declines in revenue and profitability, along with technical indicators suggesting potential overbought conditions, present risks. The stock is moderately valued, and the absence of a dividend yield may deter income-focused investors.

Positive Factors

Earnings Performance

Earnings growth significantly outpaced revenue growth, with EPS rising 40% to $0.21.

Revenue Growth

Revenue grew 13% year-over-year to $15.0M, driven by strong online sales and contributions from recently acquired brands.

Strategic Positioning

FitLife's unique position executing a roll-up strategy in the fragmented supplement industry offers a compelling opportunity for investors.

Negative Factors

Share Price Concerns

Despite significant share price growth, further multiple expansion can be supported by growth in existing brands and expanding the portfolio with new brands.

FitLife Brands Business Overview & Revenue Model

Company Description

FitLife Brands, Inc. provides nutritional supplements for health-conscious consumers in the United States and internationally. It offers weight loss, general health, and sports nutrition supplements; precision sports nutrition formulations for professional muscular development; weight loss and sports nutrition performance enhancing supplements for fitness enthusiasts; and men's health and weight loss formulations, as well as other diet, health, and sports nutrition supplements and related products; and sports nutritional products, energy and weight loss products, and meal replacements. It markets its products under the brand names of NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Metis Nutrition, iSatori, BioGenetic Laboratories, and Energize through franchised stores, as well as through various retail locations, including specialty, mass, and online. The company was formerly known as Bond Laboratories, Inc. and changed its name to FitLife Brands, Inc. in September 2013. FitLife Brands, Inc. was incorporated in 2005 and is headquartered in Omaha, Nebraska.

How the Company Makes Money

FitLife Brands generates revenue primarily through the sale of its nutritional supplements and health-related products. The company utilizes a multi-channel distribution approach, selling directly to consumers via its e-commerce platforms, as well as through retail partnerships with health food stores, gyms, and other fitness-related establishments. Key revenue streams include product sales from both online and offline channels, with a focus on expanding its market presence through strategic partnerships and collaborations. Additionally, FitLife Brands may benefit from brand licensing agreements and promotional deals that enhance its visibility and customer reach, contributing to its overall earnings.

FitLife Brands Financial Statement Overview

Summary

FitLife Brands demonstrates strong financial performance with solid revenue growth, robust profitability, conservative leverage, and strong cash flow generation. The company maintains effective cost management and operational efficiency, though vigilance on maintaining margins is recommended.

Income Statement

FitLife Brands has demonstrated strong revenue growth with a consistent upward trajectory, notably a 22.35% increase from 2023 to 2024. The company's gross profit margin is robust at 43.55%, complemented by a healthy net profit margin of 13.93%. EBIT and EBITDA margins are also strong at 20.36% and 20.71% respectively, indicating effective cost management and operational efficiency. Overall, the income statement reflects solid profitability, though continued vigilance on maintaining margins is recommended.

Balance Sheet

FitLife Brands exhibits a solid balance sheet with a low debt-to-equity ratio of 0.14, indicating conservative leverage. The equity ratio stands at 61.72%, showcasing a strong equity base relative to total assets. Return on equity is impressive at 24.86%, highlighting effective utilization of equity to generate profits. While the balance sheet is stable, attention to maintaining low leverage and high equity levels will be crucial.

Cash Flow

The company shows significant growth in free cash flow, with a 133.35% increase from 2023 to 2024. Operating cash flow to net income ratio is 1.07, indicating good cash generation relative to net income. The free cash flow to net income ratio is 1.07, demonstrating strong cash flow conversion. The cash flow statement reflects healthy cash management and operational strength, supporting future growth and investment.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	63.86M	64.47M	52.70M	28.80M	27.90M	21.74M
Gross Profit	27.67M	28.08M	21.43M	12.03M	12.49M	9.39M
EBITDA	12.91M	13.35M	8.12M	5.89M	6.81M	4.38M
Net Income	8.84M	8.98M	5.30M	4.43M	5.41M	8.82M
Balance Sheet
Total Assets	62.19M	58.53M	55.35M	25.71M	21.48M	16.77M
Cash, Cash Equivalents and Short-Term Investments	5.94M	4.47M	1.14M	13.28M	9.90M	6.34M
Total Debt	4.89M	13.46M	20.15M	103.00K	158.00K	661.00K
Total Liabilities	23.27M	22.41M	28.31M	4.32M	4.19M	4.74M
Stockholders Equity	38.92M	36.13M	27.04M	21.39M	17.29M	12.03M
Cash Flow
Free Cash Flow	6.88M	9.60M	4.11M	4.13M	4.48M	5.72M
Operating Cash Flow	6.90M	9.61M	4.22M	4.13M	4.48M	5.72M
Investing Cash Flow	-24.00K	-10.00K	-35.99M	0.00	-529.00K	0.00
Financing Cash Flow	-4.22M	-6.98M	20.30M	-750.00K	-390.00K	350.00K

FitLife Brands Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 18.43
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FTLF, the sentiment is Positive. The current price of 18.43 is above the 20-day moving average (MA) of 15.59, above the 50-day MA of 14.18, and above the 200-day MA of 14.72, indicating a bullish trend. The MACD of 1.10 indicates Negative momentum. The RSI at 75.57 is Negative, neither overbought nor oversold. The STOCH value of 86.45 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FTLF.

FitLife Brands Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
NATR	80 Outperform	$290.99M	22.12	9.15%	―	4.33%	-6.33%
FTLF	75 Outperform	$173.08M	22.54	21.88%	―	3.91%	-1.39%
LFVN	74 Outperform	$162.77M	18.46	30.11%	1.28%	8.22%	159.71%
Sector *	63 Neutral	$20.46B	14.47	-3.60%	3.13%	2.63%	-6.18%
PAVS	43 Neutral	$46.80M	―	-44.18%	―	-98.91%	―
LSF	42 Neutral	$61.96M	―	-8.34%	―	22.79%	74.00%
BRLS	31 Underperform	$64.17M	―	-5302.44%	―	115.44%	16.23%

FitLife Brands Corporate Events

FitLife Brands Updates Corporate Presentation Strategy

On August 19, 2025, FitLife Brands, Inc. implemented a new corporate presentation for its business operations. This update is part of their ongoing efforts to enhance corporate communication and potentially improve stakeholder engagement.

FitLife Brands Reports Q2 2025 Revenue Decline

FitLife Brands reported a 5% decrease in total revenue for the second quarter of 2025, amounting to $16.1 million, compared to the same period in 2024. The decline in revenue and net income, which fell from $2.6 million to $1.7 million, was largely due to merger and acquisition-related expenses associated with the Irwin Naturals transaction. Online revenue, which makes up 65% of total revenue, also decreased by 7%. Despite these declines, the company ended the quarter with $10.9 million outstanding on its term loans and $6.6 million in cash, resulting in a total net debt of $4.3 million.

FitLife Brands Holds 2025 Annual Stockholders Meeting

On August 12, 2025, FitLife Brands, Inc. held its 2025 Annual Meeting of Stockholders, where several key proposals were voted upon. The election of directors resulted in the re-election of all nominated individuals to the Board until the 2026 Annual Meeting. Additionally, stockholders approved the executive compensation on a non-binding advisory basis and decided that future advisory votes on executive compensation will occur every three years. Furthermore, the appointment of Weinberg & Company, P.A. as the independent auditors for the fiscal year ending December 31, 2025, was ratified.

FitLife Brands Completes Acquisition of Irwin Naturals

On August 8, 2025, FitLife Brands successfully closed the acquisition of substantially all assets of Irwin Naturals and its affiliates for $42.5 million, following approval by the U.S. Bankruptcy Court for the Central District of California. The acquisition, funded through a combination of a new term loan, a revolving line of credit, and FitLife’s cash reserves, is expected to drive revenue and earnings growth, enhancing FitLife’s market position in the nutritional supplements industry.

FitLife Brands Acquires Irwin Naturals for $42.5 Million

On July 31, 2025, FitLife Brands received approval from the U.S. Bankruptcy Court to acquire substantially all assets of Irwin Naturals for $42.5 million, with the transaction expected to close on August 8, 2025. This acquisition is anticipated to double the company’s size, with projected consolidated revenue exceeding $120 million and adjusted EBITDA between $20-25 million for the first full year. The acquisition is strategically significant as it combines complementary product lines and sales channels, enhancing FitLife’s market presence and operational efficiency. The transaction is expected to be accretive to shareholders and funded through a combination of cash, a new term loan, and a revolving credit facility.